Loading...
OTCM
TXTM
Market cap9mUSD
Jul 16, Last price  
0.00USD
1D
10.11%
1Q
512.50%
Jan 2017
1,125.00%
IPO
-100.00%
Name

Protext Mobility Inc

Chart & Performance

D1W1MN
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
15.25%
Rev. gr., 5y
-30.66%
Revenues
0k
4,3994,5566661,722,984319,30984,57093,37131,42830,85325,69210,63464200000000
Net income
-54k
L
-594,672-1,068,433-1,338,235-3,780,325-3,951,743-6,264,492-5,190,030-4,480,910-5,678,989-3,588,824-2,169,751-1,447,373-290,400-548,604-513,130-1,503,391-506,032-142,288525,151-54,272
CFO
-44k
-6,812-1,159,736-514,610-998,657-2,264,213-2,427,318-1,179,732-2,164,799-2,390,370-761,336-629,607-365,656-253,840-78,418000-44,243

Profile

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc.
URL
http://ww1.protextm.co/
IPO date
Aug 21, 2003
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
(168)
(228)
Tax Rate
NOPAT
168
228
Net income
(54)
-110.33%
525
-469.08%
Dividends
Dividend yield
Proceeds from repurchase of equity
3
BB yield
-0.03%
Debt
Debt current
62
9
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
62
9
Cash flow
Cash from operating activities
(44)
CAPEX
Cash from investing activities
Cash from financing activities
44
FCF
168
(15,471)
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
(3,479)
(3,425)
Invested Capital
17,918
17,864
ROIC
0.94%
2.24%
ROCE
EV
Common stock shares outstanding
8,791,222
8,372,592
Price
0.00
13.33%
0.00
7.14%
Market cap
14,945
19.00%
12,559
14.55%
EV
15,010
12,570
EBITDA
EV/EBITDA
Interest
2
14
Interest/NOPBT